What People are Saying About the BIO CEO & Investo
Post# of 30027
"I have attended BIO’s events for more than 10 years as an in-house IR executive and now as the CEO and Founder of my own firm representing public and private biotech companies. It’s apparent that a lot of thought goes into their investor screening/qualification process. Several of my clients are attending BIO CEO in February, and as soon as the meeting system opens, we plan to take full advantage to build out robust meeting schedules yet again."
-Jenene Thomas, Founder & CEO, Jenene Thomas Communications
Jenene is Amarantus IR contact.